Nava María Paulina, Ibarra Bertha, Magaña María Teresa, de la Luz Chávez María, Perea F Javier
División de Genética, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Sierra Mojada No. 800, Colonia Independencia, CP 44340, Guadalajara, Jalisco, México.
Blood Cells Mol Dis. 2006 Mar-Apr;36(2):255-8. doi: 10.1016/j.bcmd.2005.12.003. Epub 2006 Feb 7.
The aim of this study was to determine the frequency of alpha-globin gene mutations in three groups of Mexican unrelated individuals. The first two groups were normal and sickle cell trait individuals from the Costa Chica region, a place with a 12.8% frequency of HbS carriers, and the third group comprised of Mexican mestizo patients with beta-thalassemia. We searched for -alpha(3.7) and -alpha(4.2) alpha(+)-thalassemia deletion alleles, as well as the alpha alpha alpha(anti3.7) triplication through long-gap PCR. The alleles -alpha(3.7) and alpha alpha alpha(anti3.7) were found in the heterozygote state only; 19% of the normal subjects had the -alpha(3.7) allele, and 2% showed the alpha alpha alpha(anti3.7) allele. In individuals with the sickle cell trait, 17% had the -alpha(3.7) deletion, and the alpha alpha alpha(anti3.7) triplication was observed in 3% of these individuals. We revealed that 16% of the subjects with beta-thalassemia showed the -alpha(3.7) deletion and 28% the alpha alpha alpha(anti3.7) triplication. The -alpha(4.2) deletion was not detected in any individual. The frequency of the -alpha(3.7) allele was roughly the same in the three groups studied; this can be explained by the fact that the three groups have common genes from Africa and the Mediterranean, where a high prevalence of alpha(+)-thalassemia has been observed. To our knowledge, the frequency of alpha alpha alpha(anti3.7) triplication observed in the Mexican beta-thalassemia patients is the highest reported. As the -alpha(3.7) and alpha alpha alpha(anti3.7) alleles are very common in our selected populations, we believe that there is a need to investigate systematically the alpha-globin gene mutations in all hemoglobinopathies in the Mexican population.
本研究的目的是确定三组墨西哥非亲属个体中α-珠蛋白基因突变的频率。前两组是来自科斯塔奇卡地区的正常个体和镰状细胞性状个体,该地区HbS携带者的频率为12.8%,第三组由患有β-地中海贫血的墨西哥混血患者组成。我们通过长片段PCR寻找-α(3.7)和-α(4.2)α(+)-地中海贫血缺失等位基因,以及ααα(anti3.7)三联体。-α(3.7)和ααα(anti3.7)等位基因仅在杂合子状态下被发现;19%的正常受试者有-α(3.7)等位基因,2%显示有ααα(anti3.7)等位基因。在患有镰状细胞性状的个体中,17%有-α(3.7)缺失,3%的个体观察到ααα(anti3.7)三联体。我们发现,16%的β-地中海贫血受试者显示有-α(3.7)缺失,28%有ααα(anti3.7)三联体。在任何个体中均未检测到-α(4.2)缺失。-α(3.7)等位基因在研究的三组中频率大致相同;这可以用以下事实来解释,即这三组都有来自非洲和地中海的共同基因,在这些地区观察到α(+)-地中海贫血的高患病率。据我们所知,在墨西哥β-地中海贫血患者中观察到的ααα(anti3.7)三联体频率是报道中最高的。由于-α(3.7)和ααα(anti3.7)等位基因在我们选定的人群中非常常见,我们认为有必要系统地研究墨西哥人群中所有血红蛋白病的α-珠蛋白基因突变。